PT1685150E - Novos inibidores da 17beta-hidroxi-esteróide desidrogenase de tipo i - Google Patents

Novos inibidores da 17beta-hidroxi-esteróide desidrogenase de tipo i Download PDF

Info

Publication number
PT1685150E
PT1685150E PT04804529T PT04804529T PT1685150E PT 1685150 E PT1685150 E PT 1685150E PT 04804529 T PT04804529 T PT 04804529T PT 04804529 T PT04804529 T PT 04804529T PT 1685150 E PT1685150 E PT 1685150E
Authority
PT
Portugal
Prior art keywords
inhibitors
novel
hydroxysteroid dehydrogenase
dehydrogenase type
17beta
Prior art date
Application number
PT04804529T
Other languages
English (en)
Inventor
Josef Messinger
Nina Johansson
Pasi Koskimies
Heinrich-Hubert Thole
Bettina Husen
Bartholomeus Johannes Van Steen
Gyula Schneider
Johannes Bernardus Everardus Hulshof
Jerzy Adamski
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of PT1685150E publication Critical patent/PT1685150E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT04804529T 2003-11-12 2004-11-11 Novos inibidores da 17beta-hidroxi-esteróide desidrogenase de tipo i PT1685150E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104169 2003-11-12
EP04105313 2004-10-26

Publications (1)

Publication Number Publication Date
PT1685150E true PT1685150E (pt) 2008-11-12

Family

ID=34593637

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04804529T PT1685150E (pt) 2003-11-12 2004-11-11 Novos inibidores da 17beta-hidroxi-esteróide desidrogenase de tipo i

Country Status (22)

Country Link
EP (1) EP1685150B1 (pt)
JP (1) JP4778438B2 (pt)
KR (1) KR101070025B1 (pt)
AR (1) AR046580A1 (pt)
AT (1) ATE407139T1 (pt)
AU (1) AU2004289459B2 (pt)
BR (1) BRPI0416551A (pt)
CA (1) CA2545704C (pt)
DE (1) DE602004016373D1 (pt)
DK (1) DK1685150T3 (pt)
ES (1) ES2314478T3 (pt)
HK (1) HK1099309A1 (pt)
HR (1) HRP20080603T3 (pt)
IL (1) IL175220A (pt)
NO (1) NO20062679L (pt)
PL (1) PL1685150T3 (pt)
PT (1) PT1685150E (pt)
RU (1) RU2369614C2 (pt)
SA (1) SA04250373B1 (pt)
SI (1) SI1685150T1 (pt)
TW (1) TWI331154B (pt)
WO (1) WO2005047303A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004025985A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estriol- und Estetrol-Prodrugs
DE102004025966A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estradiol-Prodrugs
CN102796160A (zh) * 2005-05-26 2012-11-28 索尔瓦药物有限公司 17β-HSD1和STS抑制剂
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
WO2007096647A2 (en) * 2006-02-27 2007-08-30 Sterix Limited Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
US8080540B2 (en) 2006-09-19 2011-12-20 Abbott Products Gmbh Therapeutically active triazoles and their use
RU2469042C2 (ru) * 2006-09-19 2012-12-10 Зольвай Фармасьютиклз Гмбх Терапевтически активные триазолы и их использование
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
CN101568547B (zh) * 2006-11-30 2014-06-25 索尔瓦药物有限公司 作为17βHSD抑制剂的被取代的雌三烯衍生物
US8288367B2 (en) 2006-11-30 2012-10-16 Solvay Pharmaceuticals Gmbh Substituted estratriene derivatives as 17BETA HSD inhibitors
DE102007015169A1 (de) 2007-03-27 2008-10-02 Universität des Saarlandes Campus Saarbrücken 17Beta-Hydroxysteroid-Dehydrogenase-Typ1-Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
DE102007040243A1 (de) * 2007-08-25 2009-02-26 Universität des Saarlandes 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
KR20130108586A (ko) 2010-09-23 2013-10-04 애브비 인코포레이티드 아자아다만탄 유도체의 일수화물
EP2688901B1 (en) 2011-03-25 2019-05-08 Université Laval INHIBITORS OF 17ß-HSD1, 17ß-HSD3 AND 17ß-HSD10
JP6461127B2 (ja) 2013-06-25 2019-01-30 フォレンド ファーマ リミテッド １７βヒドロキシステロイド脱水素酵素、タイプＩの阻害剤としての治療活性エストラトリエンチアゾール誘導体
US9663549B2 (en) * 2013-06-25 2017-05-30 Forendo Pharma Ltd. Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase
CN105518017B (zh) 2013-06-25 2020-07-14 佛恩多制药有限公司 治疗活性的作为1型17β-羟基类固醇脱氢酶抑制剂的雌三烯噻唑衍生物
WO2016102776A1 (en) 2014-12-23 2016-06-30 Forendo Pharma Ltd Prodrugs of 17.beta.-hsd1 -inhibitors
JP6545266B2 (ja) * 2014-12-23 2019-07-17 フォレンド ファーマ リミテッド １７β‐ＨＳＤ１抑制剤のプロドラッグ
CZ307437B6 (cs) 2016-06-07 2018-08-22 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. 15β-substituované deriváty estronu jako selektivní inhibitory 17β-hydroxysteoiddehydrogenáz
DK3634975T3 (da) * 2017-06-08 2024-05-27 Organon R&D Finland Ltd 17-oximer af 15.beta.-[3-propanamido]-substituerede estra-1,3,5(10)-trien-17-oner til anvendelse i inhibition af 17.beta.-hydroxysteroid-dehydrogenaser
EP3891167A1 (en) * 2018-12-05 2021-10-13 Forendo Pharma Ltd Estra-1,3,5(10)-triene compounds condensed in position 16(17) with a pyrazole ring as inhibitors of 17-hsd1

Also Published As

Publication number Publication date
DE602004016373D1 (de) 2008-10-16
RU2006120488A (ru) 2008-01-10
HRP20080603T3 (en) 2009-03-31
SI1685150T1 (sl) 2008-12-31
IL175220A (en) 2010-12-30
NO20062679L (no) 2006-08-10
AU2004289459B2 (en) 2010-08-19
AR046580A1 (es) 2005-12-14
EP1685150B1 (en) 2008-09-03
AU2004289459A1 (en) 2005-05-26
ES2314478T3 (es) 2009-03-16
TW200521133A (en) 2005-07-01
TWI331154B (en) 2010-10-01
KR101070025B1 (ko) 2011-10-04
SA04250373B1 (ar) 2009-12-22
HK1099309A1 (en) 2007-08-10
JP4778438B2 (ja) 2011-09-21
DK1685150T3 (da) 2008-12-01
WO2005047303A2 (en) 2005-05-26
BRPI0416551A (pt) 2007-02-27
JP2007510697A (ja) 2007-04-26
RU2369614C2 (ru) 2009-10-10
WO2005047303A3 (en) 2005-08-25
ATE407139T1 (de) 2008-09-15
PL1685150T3 (pl) 2009-02-27
IL175220A0 (en) 2006-09-05
EP1685150A2 (en) 2006-08-02
CA2545704A1 (en) 2005-05-26
CA2545704C (en) 2012-06-26
KR20060121171A (ko) 2006-11-28
SA04250373A (ar) 2005-12-03

Similar Documents

Publication Publication Date Title
IL175220A0 (en) Novel 17?? hydroxysteroid dehydrogenase type i inhibitors
HK1087331A1 (en) Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors
AU2003299034A8 (en) Transdermal compositions
EG25482A (en) Inhibitors
HK1091838A1 (en) Gfat inhibitors
AU2003205168A8 (en) Make up application kit
AU2003230392A8 (en) Beta-secretase inhibitors
EP1614746A4 (en) FRUCTOSYLAMINE OXIDASE
GB2407097B (en) Dishwasher anti-corrosion composition
EP1474532A4 (en) POLYMERASE COMPOSITIONS
GB0312619D0 (en) Complement inhibitors
GB0211241D0 (en) Sliding tee
GB0218302D0 (en) Transistor
GB2388503B (en) Channel estimation
GB0327386D0 (en) Complement inhibitors
GB0329869D0 (en) Inhibitors
GB0300607D0 (en) Inhibitors
GB0329998D0 (en) Enzyme inhibitors
GB0313814D0 (en) Enzyme inhibitors
GB0312240D0 (en) Enzyme inhibitors
GB0306188D0 (en) Enzyme inhibitors
AU2003907173A0 (en) Drain Brush
GB0208094D0 (en) Inhibitors
GB0217330D0 (en) Inhibitors
GB0206031D0 (en) Inhibitors